SOC Telemed Inc. Class A (TLMD) Financials

$3.00

$0.00 (0.00%)

As on 06-Apr-2022 09:30EDT

Market cap

$304 Mln

Revenue (TTM)

$94 Mln

P/E Ratio

--

P/B Ratio

1.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Operating Revenue	94.44	58.00	66.20	--	--	--
Cost of Revenue	64.09	38.54	40.21	--	--	--
Gross Profit	30.35	19.45	25.99	--	--	--
Operating Expenses	86.61	61.28	35.93	--	--	--
Operating Profit (EBIT)	-52.99	-41.83	-8.09	--	--	--
Other Income	--	4.24	--	--	--	--
Profit before Tax	-50.69	-49.82	-18.23	--	--	--
Provision for Tax	0.15	0.03	0.01	-1.76	--	--
Profit after Tax (Net Income)	-50.54	-49.85	-18.24	--	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	-146.82	-23.76	-22.20	--	--

Liabilities ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Shareholder's Funds	167.13	55.07	-38.03	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	88.92	13.93	77.95	--	--	--
Current Liabilities	18.18	15.94	10.08	9.50	--	--
Total Liabilities	274.23	84.94	50.00	--	--	--

Assets ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Non-Current Assets	213.91	35.86	34.07	--	--	--
Current Assets	60.32	49.08	15.93	14.67	--	--
Total Assets	274.23	84.94	49.99	--	--	--
Total Debt*	86.71	--	77.19	--	--	--
Net Current Assets	42.14	33.14	5.85	--	--	--

Cashflow ($ Mln)	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Cash From Operating Activities	-40.08	-22.58	-10.77	-13.70	--	--
Cash Flow from Investing Activities	--	-6.53	-5.23	-14.50	--	--
Cash from Financing Activities	134.26	63.32	16.55	22.82	--	--
Net Cash Inflow / Outflow	--	34.21	--	--	--	--

Financials Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Adjusted EPS ($)	-0.56	-1.22	--	--	--	--
Cash EPS ($)	-0.45	-1.08	--	--	--	--
Adjusted Book Value ($)	1.84	1.34	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-0.44	-0.55	--	--	--	--
Free Cash Flow per Share ($)	-0.47	-0.71	--	--	--	--

Profitability Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
ROCE (%)	-32.72	-105.81	-93.17	--	--	--
ROE (%)	-45.49	-585.23	47.97	--	--	--
ROA (%)	-28.14	-73.88	-36.48	--	--	--
EBIT Margin (%)	-46.16	-64.81	-11.97	--	--	--
Net Margin (%)	-53.52	-80.10	-27.56	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Revenue Growth (%)	0.63	-0.12	--	--	--	--
EBIT Growth (%)	-15.96	-374.25	11.14	--	--	--
Net Profit Growth (%)	-1.39	-173.25	--	--	--	--
EPS Growth (%)	0.54	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Price / Earnings	-2.30	-6.45	--	--	--	--
Price / Book Value	0.70	5.84	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-4.79	-8.81	--	--	--	--
Close Price ($)	1.28	7.84	--	--	--	--
High Price ($)	9.48	12.08	--	--	--	--
Low Price ($)	1.22	7.22	--	--	--	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debt to Equity	0.52	--	-2.03	--	--	--
Short term debt to equity ratio	--	--	0.00	--	--	--
Current Ratio	3.32	3.08	1.58	1.54	--	--
Quick Ratio	3.28	--	--	--	--	--
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12	Dec-11
Debtors to sales (%)	18.89	15.04	15.93	--	--	--
Asset Turnover	0.53	0.86	1.32	--	--	--
Receivable days	51.36	60.67	56.19	--	--	--
Inventory Days	4.30	--	--	--	--	--
Payable days	22.19	29.59	27.52	--	--	--
Cash Conversion Cycle	33.47	--	--	--	--	--